THE DEAL, AT A GLANCE
2/4 reviewedMagnitude Biosciences
Magnitude Biosciences
Magnitude Biosciences runs worm-based testing services that help researchers study drug effects and safety.
Magnitude Biosciences raised announced 2026-09-1501What it doesMagnitude Biosciences runs worm-based testing services that help researchers study drug effects and safety.Source-grounded · automated review · Explore ↗
Checked 2026-10-07 · Review due 2026-10-14
Read supporting source ↗Our customised C. elegans studies…
02What happenedMagnitude Biosciences raised announced 2026-09-15From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersIts tests can help drug developers rank compounds earlier using automated imaging results.Interpretation · Explore ↗
Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗
Magnitude Biosciences · Financing Record
Explore source-linked visual explanations for Magnitude Biosciences. Unsupported claims are withheld while source review continues.
Record 12315 · Recorded date: 2026-09-15
Explore company records →